SRPT logo

Sarepta Therapeutics (SRPT) Shareholders equity

annual shareholders equity:

$1.53B+$668.40M(+77.78%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SRPT annual stockholders equity is $1.53 billion, with the most recent change of +$668.40 million (+77.78%) on December 31, 2024.
  • During the last 3 years, SRPT annual shareholders equity has risen by +$599.73 million (+64.63%).
  • SRPT annual shareholders equity is now at all-time high.

Performance

SRPT Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTbalance sheet metrics

quarterly shareholders equity:

$1.14B-$385.02M(-25.20%)
March 1, 2025

Summary

  • As of today (May 29, 2025), SRPT quarterly stockholders equity is $1.14 billion, with the most recent change of -$385.02 million (-25.20%) on March 1, 2025.
  • Over the past year, SRPT quarterly shareholders equity has increased by +$181.53 million (+18.89%).
  • SRPT quarterly shareholders equity is now -25.20% below its all-time high of $1.53 billion, reached on December 31, 2024.

Performance

SRPT quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

SRPT Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+77.8%+18.9%
3 y3 years+64.6%+33.4%
5 y5 years+86.7%-0.2%

SRPT Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+296.9%-25.2%+196.8%
5 y5-yearat high+296.9%-25.2%+196.8%
alltimeall timeat high>+9999.0%-25.2%>+9999.0%

SRPT Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$1.14B(-25.2%)
Dec 2024
$1.53B(+77.8%)
$1.53B(+25.1%)
Sep 2024
-
$1.22B(+13.4%)
Jun 2024
-
$1.08B(+12.1%)
Mar 2024
-
$961.19M(+11.9%)
Dec 2023
$859.34M(+123.2%)
$859.34M(+12.4%)
Sep 2023
-
$764.36M(+3.1%)
Jun 2023
-
$741.41M(+4.0%)
Mar 2023
-
$712.75M(+85.2%)
Dec 2022
$384.95M(-58.5%)
$384.95M(-10.7%)
Sep 2022
-
$430.84M(-40.7%)
Jun 2022
-
$726.46M(-15.2%)
Mar 2022
-
$856.89M(-7.7%)
Dec 2021
$928.01M(+21.8%)
$928.01M(+97.6%)
Sep 2021
-
$469.53M(-3.2%)
Jun 2021
-
$485.11M(-9.4%)
Mar 2021
-
$535.45M(-29.7%)
Dec 2020
$761.76M(-6.9%)
$761.76M(-14.6%)
Sep 2020
-
$892.05M(-14.5%)
Jun 2020
-
$1.04B(-8.9%)
Mar 2020
-
$1.14B(+39.9%)
Dec 2019
$818.19M(-20.7%)
$818.19M(-17.8%)
Sep 2019
-
$995.20M(-9.5%)
Jun 2019
-
$1.10B(-18.5%)
Mar 2019
-
$1.35B(+30.6%)
Dec 2018
$1.03B(+30.8%)
$1.03B(+61.3%)
Sep 2018
-
$639.85M(-8.5%)
Jun 2018
-
$699.05M(-10.0%)
Mar 2018
-
$776.76M(-1.6%)
Dec 2017
$789.22M(+134.4%)
$789.22M(+13.2%)
Sep 2017
-
$697.16M(+84.5%)
Jun 2017
-
$377.77M(-12.0%)
Mar 2017
-
$429.14M(+27.5%)
Dec 2016
$336.69M(+76.9%)
$336.69M(-17.6%)
Sep 2016
-
$408.62M(+236.4%)
Jun 2016
-
$121.46M(-12.6%)
Mar 2016
-
$138.96M(-27.0%)
Dec 2015
$190.35M(-23.1%)
$190.35M(+54.5%)
Sep 2015
-
$123.24M(-25.5%)
Jun 2015
-
$165.38M(-17.6%)
Mar 2015
-
$200.76M(-18.9%)
Dec 2014
$247.65M(+0.2%)
$247.65M(-13.5%)
Sep 2014
-
$286.20M(-4.6%)
Jun 2014
-
$299.92M(+31.0%)
Mar 2014
-
$228.96M(-7.4%)
Dec 2013
$247.19M(+99.9%)
$247.19M(+0.1%)
Sep 2013
-
$246.98M(+178.1%)
Jun 2013
-
$88.82M(+1.8%)
Mar 2013
-
$87.28M(-29.4%)
Dec 2012
$123.68M(+298.7%)
$123.68M(-2808.7%)
Sep 2012
-
-$4.57M(-120.3%)
Jun 2012
-
$22.50M(+60.5%)
Mar 2012
-
$14.02M(-54.8%)
Dec 2011
$31.02M(-1201.1%)
$31.02M(-2.3%)
Sep 2011
-
$31.75M(-9.7%)
Jun 2011
-
$35.15M(+3720.5%)
Mar 2011
-
$920.00K(-132.7%)
DateAnnualQuarterly
Dec 2010
-$2.82M(-111.9%)
-$2.82M(-167.7%)
Sep 2010
-
$4.16M(-50.7%)
Jun 2010
-
$8.44M(-64.0%)
Mar 2010
-
$23.47M(-0.7%)
Dec 2009
$23.63M(+50.2%)
$23.63M(+21.2%)
Sep 2009
-
$19.50M(+414.9%)
Jun 2009
-
$3.79M(-83.5%)
Mar 2009
-
$22.89M(+45.5%)
Dec 2008
$15.73M(-40.4%)
$15.73M(-3.7%)
Sep 2008
-
$16.34M(-23.1%)
Jun 2008
-
$21.24M(+2.2%)
Mar 2008
-
$20.79M(-21.2%)
Dec 2007
$26.38M(-30.0%)
$26.38M(+73.3%)
Sep 2007
-
$15.23M(-37.1%)
Jun 2007
-
$24.21M(-21.8%)
Mar 2007
-
$30.96M(-17.9%)
Dec 2006
$37.71M(-29.7%)
$37.71M(-15.0%)
Sep 2006
-
$44.36M(-11.5%)
Jun 2006
-
$50.12M(-10.4%)
Mar 2006
-
$55.91M(+4.2%)
Dec 2005
$53.66M(+104.3%)
$53.66M(+45.1%)
Sep 2005
-
$36.99M(-4.2%)
Jun 2005
-
$38.62M(-11.1%)
Mar 2005
-
$43.42M(+65.3%)
Dec 2004
$26.27M(-39.5%)
$26.27M(-15.3%)
Sep 2004
-
$31.02M(-13.8%)
Jun 2004
-
$35.98M(-16.4%)
Mar 2004
-
$43.05M(-0.8%)
Dec 2003
$43.39M(+84.8%)
$43.39M(+24.7%)
Sep 2003
-
$34.81M(-9.2%)
Jun 2003
-
$38.33M(+94.4%)
Mar 2003
-
$19.71M(-16.1%)
Dec 2002
$23.48M(-23.1%)
$23.48M(-9.1%)
Sep 2002
-
$25.83M(-23.1%)
Jun 2002
-
$33.58M(-16.9%)
Mar 2002
-
$40.42M(+32.4%)
Dec 2001
$30.53M(-8.5%)
$30.53M(-3.2%)
Sep 2001
-
$31.56M(-16.4%)
Jun 2001
-
$37.76M(+30.9%)
Mar 2001
-
$28.84M(-13.6%)
Dec 2000
$33.37M(+180.4%)
$33.37M(-13.8%)
Sep 2000
-
$38.70M(+241.8%)
Jun 2000
-
$11.32M(-24.6%)
Mar 2000
-
$15.02M(+26.3%)
Dec 1999
$11.90M(+32.2%)
$11.90M(+283.9%)
Sep 1999
-
$3.10M(-41.5%)
Jun 1999
-
$5.30M(-27.4%)
Mar 1999
-
$7.30M(-18.9%)
Dec 1998
$9.00M(-50.8%)
$9.00M(-21.1%)
Sep 1998
-
$11.40M(-26.0%)
Jun 1998
-
$15.40M(-9.4%)
Mar 1998
-
$17.00M(-7.1%)
Dec 1997
$18.30M(+369.2%)
$18.30M(-1.6%)
Sep 1997
-
$18.60M(+5.7%)
Jun 1997
-
$17.60M(+8700.0%)
Mar 1997
-
$200.00K
Dec 1996
$3.90M
-

FAQ

  • What is Sarepta Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Sarepta Therapeutics?
  • What is Sarepta Therapeutics annual shareholders equity year-on-year change?
  • What is Sarepta Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Sarepta Therapeutics?
  • What is Sarepta Therapeutics quarterly shareholders equity year-on-year change?

What is Sarepta Therapeutics annual stockholders equity?

The current annual shareholders equity of SRPT is $1.53B

What is the all time high annual shareholders equity for Sarepta Therapeutics?

Sarepta Therapeutics all-time high annual stockholders equity is $1.53B

What is Sarepta Therapeutics annual shareholders equity year-on-year change?

Over the past year, SRPT annual stockholders equity has changed by +$668.40M (+77.78%)

What is Sarepta Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of SRPT is $1.14B

What is the all time high quarterly shareholders equity for Sarepta Therapeutics?

Sarepta Therapeutics all-time high quarterly stockholders equity is $1.53B

What is Sarepta Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, SRPT quarterly stockholders equity has changed by +$181.53M (+18.89%)
On this page